RecruitingNCT03237026

Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients

Decipher the Biology of Lethal Prostate Cancer-Using Urine Metabolomics and Proteomics Profiling to Search for Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients


Sponsor

National Taiwan University Hospital

Enrollment

360 participants

Start Date

Oct 11, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to identify potential urine marker metabolites as predictive or prognostic markers for treatment outcomes in patients with prostate cancer.


Eligibility

Sex: MALEMin Age: 30 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting urine samples and medical information from prostate cancer patients to identify biological markers that can predict how well different treatments will work. **You may be eligible if...** - You have been diagnosed with prostate cancer confirmed by a tissue biopsy - You are between 30 and 100 years old - You are planning to receive at least one of: surgery, radiation, chemotherapy, or hormone therapy for prostate cancer **You may NOT be eligible if...** - You have another active cancer that has not been treated or cured for at least 3 years (or any bladder or kidney cancer at any point) - You have severely impaired kidney or heart function, or uncontrolled diabetes - You have had a significant infection or inflammation within the past 8 weeks - Your life expectancy is less than 12 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention required

No intervention required


Locations(1)

National Taiwan University

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03237026


Related Trials